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Abstract 
Over the past two and a half years, I have studied fundamental aspects of astrocyte biology 
by investigating the existence and mechanism of astrocyte local translation peripherally 
around tripartite synapses consisting of pre- and post-synaptic neuron terminals and an 
associated astrocyte. Astrocytes are critical components of central nervous system synapses 
(which are predominately tripartite in nature4); thus, it is important to consider how 
astrocyte dysregulation and dysfunction could contribute to the pathogenesis of diseases of 
synaptic connectivity such as autism spectrum disorders, Alzheimer’s disease, seizure 
disorders, and more. Overall, my projects involved the development of novel methods to 
identify astrocyte-specific mRNA targets and to visualize and measure local translation. 
Chapter 1: Assessing Astrocyte-Specific mRNA Candidates via Fluorescent In Situ 
Hybridization 
While it is well understood that synaptically-activated, rapid, local translation of new 
proteins mediates changes in neuronal plasticity and activity at the synapse1, it has been 
unclear whether astrocytes also utilize subcellular translation. Hallmarks of astrocyte 
function include processing and responding to synaptic changes2, so I hypothesized that, like 
neurons, astrocytes also utilize local protein synthesis as a response to synaptic changes. The 
lab’s preliminary data supports this hypothesis by showing that ribosomes and ribosome-
bound mRNAs exist in peripheral astrocyte processes (PAPs). In this chapter, I focus on 
validating the presence of PAP-enriched mRNAs, identified via a novel transcriptome 
profiling method coined “PAP TRAP” (translating ribosome affinity purification). I validated 
these transcripts with an independent in vivo method, fluorescent in situ hybridization 
(FISH), in which I create mRNA target probes and add them to coronal slices with sparsely 
labelled individual astrocytes, followed by probe detection and visualization via confocal 
microscopy. Through these experiments, I observed clear subcellular localization of multiple 
astrocyte-specific mRNAs at PAPs labelled by GFP. 
Chapter 2: Investigating Activity-Dependent Regulation of Astrocyte Local Translation 
Having demonstrated that PAP-enriched mRNAs are truly localized peripherally, I 
questioned what regulates local translation of these mRNAs. I conducted ex vivo experiments 
to test whether peripheral translation responds to treatment-induced synaptic modulation. 
I visualized protein translation in peripheral processes via puromycylation, a method to 
visualize newly made peptides. I treated acute mouse brain slices with KCl, brain-derived 
neurotrophic factor (BDNF), an mGluR5 antagonist (MTEP), an adenylate cyclase activator 
(forskolin), and a Na+ channel blocker (tetrodotoxin, TTX) to modulate synaptic activity. 
Using a novel Sholl-like analysis to quantify puromycylation, I demonstrated that astrocytes 
modulate peripheral translation in response to treatment-induced synaptic changes. 
All in all, this work contributes to ongoing research to better understand how astrocytes 
contribute to CNS functioning. Furthermore, novel methods developed through this work, 
including the PAP TRAP + RNA-seq transcriptome profiling technique and measurement of 
peripheral translation via quantification of puromycylation, can be applied more broadly to 
future neurobiological research. My thesis demonstrates that astrocytes can independently 
regulate activity in distinct subcellular regions, a novel finding that provides  insight into 
fundamental astrocytic/synaptic regulation.
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Introduction 
Astrocytes can be broadly described as specialized glial cells critical for healthy synaptic 
transmission through maintenance of ion, fluid, pH, and transmitter homeostasis at the 
synapse5. They are the most numerous cell type in the central nervous system (CNS). Based 
on their now well-known functional roles, astrocytes require the ability to actively respond 
to synaptic imbalances to maintain homeostasis; however, the mechanism of astrocyte 
response is not well defined. 
In neurons, subcellular mRNA localization and regulated translation underlie fundamental 
synaptic functions6. Until the end of the twentieth century, most of the field believed that the 
central dogma (that protein is translated from mRNA transcribed from nuclear DNA) was 
carried out in a centralized manner in neuronal nuclei and somata. However, a major shift in 
this paradigm occurred following the discovery that polyribosomes are also found in the 
bases of dendritic spines1. Over the past decade, it has become more clear that neurons 
localize RNA subcellularly to synaptic structures (signal-receiving dendrites and signal-
transmitting axons) and respond to synaptic activity via regulated translation of these 
mRNAs6. This particularly impacts synaptic plasticity, as multiple papers have linked 
dendritic local translation to, for example, BDNF7,8 and glutamate-induced9 synaptic 
plasticity. Contrary to early hypotheses, dendrites are not the only substructures locally 
translating protein; it is important to note that axonal local protein synthesis is implicated 
in axon guidance signal-directed growth10, regeneration11, and maintenance12. Beyond the 
CNS, specific subcellular mRNA localization patterns have been broadly identified in 
mammals13 and Drosophila melanogaster14, suggesting that the local proteome may be 
significantly controlled by local mRNA translation rather than energy-demanding, time-
intensive protein transport15. 
While a classical view of glia is that they passively maintain neuronal functioning and CNS 
structure, a growing body of evidence has demonstrated that glia, especially astrocytes, have 
an active role in information processing and central nervous system functioning16. Most 
neuronal synapses are tripartite in nature, consisting of pre and post-synaptic neuron tips 
and a dynamically-interacting astrocyte4. Interest in astrocytes stems from work in the early 
90s when researchers demonstrated that elevated intracellular Ca2+ levels in cultured 
astrocytes are associated with increased astrocyte excitability17,18. This work showed for the 
first time that astrocytes are excitable cells, not just passive supports for other neural cell 
types. Furthermore, astrocyte Ca2+ elevations can also be triggered by neurotransmitter 
release during synaptic activity19, providing the first evidence of neuron-astrocyte 
communication. This synaptic control of astrocyte Ca2+ level occurs through astrocytes 
expression of a wide variety of functional neurotransmitter transporters and receptors20. 
Ca2+ rises are associated with increased expression of these receptors21. 
Further evidence suggesting a dynamic and local mechanism of action in the astrocyte 
periphery is that astrocytes are highly polarized23. This polarization reflects the functional 
and biochemical compartmentalization of astrocytes. The astrocyte Ca2+ signal, and 
downstream responses, are modulated by the simultaneous activity of multiple varied 
synaptic inputs22. A single rodent astrocyte can contact up to 90,000 synapses24 and contact 
multiple cell types (astrocyte-astrocyte, astrocyte-neuron, astrocyte-blood vessel)5, so to be 
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able to adapt to an enormous barrage of simultaneous chemical activity, a local response 
mechanism is necessary. For example, perisynaptic astrocyte processes have a molecular 
profile mirroring their roles in transmitter uptake25 whereas astrocyte endfeet at the blood-
brain barrier exhibit a much higher K+ conductance than other parts of the endothelial 
membrane26. Evidence in the literature has demonstrated by in situ hybridization (ISH) that 
astrocyte-specific mRNAs, coding for proteins that transport glutamate and form the 
cytoskeleton, exist at peripheral astrocyte processes (PAPs)27–29. This data, coupled with my 
own experiments, led to the hypothesis that astrocytes utilize local translation in their distal, 
perisynaptic processes. 
In this chapter, I demonstrate in vivo that PAPs contain ribosomes. Prior work in the lab 
identified astrocyte-specific mRNA candidates via a novel technique that applies translating 
ribosome affinity purification (TRAP)30 to a crude synaptoneurosomal (SN) fraction from the 
cortex of a mouse with tagged astrocyte ribosomes. The lab coupled this technique, named 
PAP TRAP, with RNA-sequencing to reveal mRNA transcripts bound to ribosomes in PAPs. 
This result led to hypotheses about how local translation may be regulated: by subcellular 
RNA localization (explored in Chapter 1), by regulating translation in a localized manner 
(addressed in Chapter 2), or both (my eventual conclusion). To explore subcellular 
localization of identified mRNA targets, I utilized RNA in situ hybridization.  
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Methods 
Animals 
I used C57BL/6J and Aldh1L1 bacTRAP mice, housed in standard conditions with food and 
water provided ad libitum. All procedures were performed in accordance with the 
Washington University Institutional Animal Care and Use Committee (IACUC) and the 
Animal Studies Committee (ASC). 
Peripheral Astrocyte Process Translating Ribosome Affinity Purification (PAP TRAP) 
Figure 1: Overview of PAP TRAP + RNA-sequencing methodology 
used to identify PAP-enriched transcripts. Cartoon depiction of 
gradient used to isolate synaptoneurosomal (SN) fraction and TRAP 
methodology. Aldh1L1 promotor drives expression of eGFP/Rpl10a 
fusion protein, allowing capture of ribosomes by GFP IP. The lab 
applied TRAP to a PAP SN fraction (bottom right). Adapted from 
figures created by Kristina Sakers31. 
The lab bred wild-type C57BL/6J mice to mice expressing 
the TRAP transgene (eGFP/Rpl10a) under an astrocyte-
specific promotor (Aldh1L1). This produced GFP+ and 
GFP- offspring. We removed GFP+ brains from these mice 
under sterile conditions via decapitation at age P21. To 
isolate peripheral astrocyte ribosomes and their 
associated mRNAs, we homogenized the cortices of the 
dissected brains and separated a synaptoneurosome (SN) 
fraction via a sucrose percoll gradient, in addition to 
collecting an overall cortex homogenate from the 
supernatant. We then performed TRAP by 
immunoprecipitating GFP-tagged ribosomes from the 
tissue homogenates; we named this process ‘PAP TRAP’ 
when applied to the SN fraction in Aldh1L1:eGFP/Rpl10a 
mice since it is TRAP specifically applied to peripheral 
astrocyte processes present at synapses. RNA purification 
was performed using Qiagen RNEasy MinElute kit 
following manufacturer’s instructions. We performed 
RNA-sequencing cDNA library preparation from 2ng of 
RNA using the Nugen Ovation RNAseq System V2 and the 
NEBNext Ultra DNA Library. We then sequenced the 
libraries on an Illumina HiSeq 2500. 
AAV9-GFP Sparse Astrocyte Labeling 
For sparse labeling of astrocytes for microscopy, I injected 2μl of AAV9-CBA-IRES-GFP 
virus (concentration: 1012 vector genome (vg) / mL, obtained from the Hope Center Viral 
Vectors Core at Washington University) in P2 pups bilaterally in the cortex, 1.5mm from 
the midline in two regions: 1mm caudal to bregma and 2mm rostral to lambda. I performed 
injections using a 33g needle (Hamilton #7803-05) with a 50μl Hamilton syringe (#7655-
01). At a postnatal age of 3-4 weeks, I performed CO2 euthanasia and transcardial perfusion 
with PBS, followed by tissue fixation with 4% paraformaldehyde in PBS and subsequent 
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decapitation and removal of the brains. I prepared tissue for IF or FISH via cryosectioning 
and slide mounting as described below. 
Fluorescent In Situ Hybridization (FISH) 
Figure 2: FISH experimental scheme. This is a step-by-step schematic of experimental preparation for 
detecting RNA probes labeling specific mRNA targets in situ. 
I performed FISH on 14μm slide-mounted cryosections after 4% paraformaldehyde fixation 
of either Aldh1L1:eGFP/Rpl10a or AAV9-CBA-IRES-GFP tissue. I utilized Digoxigenin-
labeled antisense probes from purified PCR products containing a T7 promoter site in the 
reverse primer. Using T7 polymerase (Promega #P2075) and Dig RNA labeling Mix (Roche 
#11277073910), I performed in vitro transcription according to manufacturer’s 
instructions. I designed primers for probe templates as follows: 
Gene Forward Primer (5’ -> 3’) Reverse Primer (5’ -> 3’) 
Slc1a2 AAGCGTGTGACCAGATTCGT TAATACGACTCACTATAGGG 
TCTCCTCAACACTGCAGTCAGC 
Slc1a3 GTTCCCTCCCAATCTGGTAGA TAATACGACTCACTATAGGGC 
CTCCAGGGCAATGTACTTGT 
Sparc GCCTGGATTCCGAGCTG TAATACGACTCACTATAGGGC 
CTCCAGGGCAATGTACTTGT 
Glul CGGGCCTGCTTGTATGCTG TAATACGACTCACTATAGGG 
TCTTCTCCTGGCCGACAGTCC 
CamKiiα AGTCTCCAAGCCAACCCC TAATACGACTCACTATAGGG 
CCTGGTGTGCGCTCTAT 
Table 1: Primers for FISH probe templates. 
I hybridized the probes to the fixed tissue at 65˚C overnight in a humid chamber, followed 
by SSC buffer washes and H2O2 blocking at room temperature. 
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I detected the probes using Sheep Anti-Dig-POD (Roche #11207733910) followed by 
Tyramide Signal Amplification Cyanine 3 Tyramide (PerkinElmer #NEL704A001KT) as per 
manufacturer’s instructions. I then incubated the slides with antibodies against additional 
specific proteins (see IF below) for dual FISH/IF. 
Immunofluorescence (IF) 
For dual FISH/IF, I incubated sections with Rabbit Anti-GFAP (Dako, 1:1000) and Chicken 
Anti-GFP (Aves, 1:1000) at room temperature, followed by detection with appropriate Alexa 
conjugated secondary antibodies (Invitrogen). I counterstained nuclei with DAPI. For IF 
alone, I cryosectioned 40μm sections into PBS from post-fixed brains frozen in OCT. Sections 
were stained as described for dual FISH/IF. After removing excess buffer, edges of the 
coverslip were sealed with nail polish before imaging. 
Microscopy 
I performed confocal microscopy on an UltraVIEW VoX spinning disk microscope 
(PerkinElmer) or an AxioImager Z2 (Zeiss). Representative images are from at least 
triplicate experiments.  
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Results 
Astrocytes contained ribosomes in their distal tips in vivo 
Dendritic protein synthesis was founded following the discovery of synapse-associated 
polyribosome complexes (SPRCs), defined as polyribosomes selectively localized beneath 
pre- and post-synaptic sites on the dendrites of CNS neurons1. Thus, I began my investigation 
of local translation by testing whether astrocytes, too, ribosomes co-localized with their 
distal processes (Fig 3A). I used BAC transgenic mice in which, within astrocytes, large 
ribosomal subunit protein Rpl10a is fused with green fluorescent protein 
(Aldh1L1:eGFP/Rpl10a) to localize ribosomes in vivo30. The specificity of this labelling to 
astrocytes has been confirmed previously via IF co-labeling of common cell-specific markers 
in Alhd1L1:eGFP/Rpl10a tissue32. Small ribosomal subunit proteins are also co-localized 
with the eGFP/Rpl10a fusion protein throughout the processes (Fig 3B), consistent with my 
hypothesis that there are distal, intact ribosomes co-localized with the fusion protein in our 
animal model. 
 
Figure 3: Astrocyte ribosomes extend past GFAP+ astrocyte processes. (A) Confocal IF of an 
Aldh1L1:eGFP/Rpl10a cortical astrocyte in vivo, P21, stained for glial fibrillary acidic protein (GFAP), a marker 
of astrocyte processes5. EGFP/Rpl10a (green) shows ribosomal tags extending throughout and past GFAP+ 
processes, scale bar = 10µm. (B) Confocal IF of an Ald1L1:eGFP/Rpl10a cortical astrocyte in vivo, P21, stained 
for Rps16, a small ribosomal subunit protein. Rps16 overlaps with eGFP/Rpl10a labelling throughout 
processes, scale bar = 10µm. 
This data confirms previous work that showed free polyribosome-like structures existing in 
PAPs via electron microscopy33. 
eGFP/Rpl10a GFAP Merge / DAPI
B
A
eGFP/Rpl10a Rps16 Merge / DAPI
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PAP TRAP identified numerous ribosome-bound, astrocyte-specific transcripts 
Local translation in neurons is often transcript-specific, meaning proteins with designated 
synaptic roles are synthesized at pre and post-synaptic tips34. Thus, I hypothesized that 
astrocytes likely have their own subset of specific mRNAs localized to the PAP. To identify 
these transcripts, Kristina Sakers, a Dougherty Lab member, pulled down translating 
ribosomes in astrocytes by applying translating ribosome affinity purification (TRAP) to a 
synaptoneurosome (SN) fraction from the aforementioned Aldh1L1:eGFP/Rpl10a 
transgenic mice (see Methods, Figure 1 for full procedure). She then performed RNA-
sequencing on RNA purified from PAP TRAP samples to identify astrocyte-specific 
candidates for further investigation by comparing Cortex TRAP and PAP TRAP RNA-seq 
readouts (see Figure 1). Our analysis identified 224 transcripts enriched on PAP ribosomes 
and 116 that are depleted (‘Soma’ transcripts). The full transcript list is submitted for 
publication35. In particular, PAP-enriched transcripts included transcripts encoding proteins 
for glutamate transport (Slc1a2, Slc1a3, Glul), biosynthesis of unsaturated fatty acids (Scd1, 
Scd2, Fads1, Fads2, Elovl5, Hadha), motor/cytoskeletal support (Kiflc, Myo10), and 
intercellular signaling (Mertk, Sparc, Thbs4). There were few PAP-enriched transcripts that 
were also soma-enriched, and transcripts enriched in the soma were depleted in PAPs. 
Astrocyte-specific transcripts are localized to peripheral processes in vivo 
To validate astrocyte-specific candidates predicted by PAP TRAP and RNA-seq, I decided to 
utilize an independent method in vivo, fluorescent in situ hybridization (FISH). While PAP 
TRAP determined the sequence-specific targets enriched on astrocyte ribosomes, PAPs do 
not have a stable structure of any sort (such as axon terminals, easily identifiable by their 
synaptic vesicles) that can be used to confirm their presence in SN fractions via electron 
microscopy or other high-resolution methods. Therefore, utilizing FISH independent of PAP 
TRAP allows us to verify the predicted targets identified by RNA-seq.  
An additional modification in the FISH experiments was the use of an AAV9 virus expressing 
GFP. This method was utilized to address the issue of densely populated astrocytes all being 
labelled by the lab’s Aldh1L1:eGFP/Rpl10a labelling method. I injected pups at P2 with this 
virus so that when euthanized and perfused at P21, the mouse brains had sparse, widespread 
GFP labelling of cortical astrocytes. Sparse labelling allows us to properly quantify individual 
astrocytes rather than having to worry about inadvertently quantifying IF from neighboring 
astrocytes. 
Using FISH, I successfully confirmed the peripheral localization of several PAP TRAP 
candidates (Slc1a2, Slc1a3, Sparc, Glul) and validated the FISH methodology by testing a no 
probe control (Figure 4). Slc1a2, Slc1a3, and Glul were also qualitatively localized to 
astrocyte cell bodies, whereas Sparc was predominately localized along processes. 
Figure 4 (below): Sparse astrocyte labeling and fluorescent in situ hybridization of astrocyte-specific 
targets reveal their peripheral localization. Early postnatal pups were injected transcranially with AAV9 
expressing GFP, resulting in sparse cortical astrocyte labeling around P21. Confocal IF of a GFP-labelled 
astrocyte shows extension of Slc1a2, Slc1a3, Sparc, and Glul FISH(red) into peripheral processes. Confocal IF of 
a GFP-labelled astrocyte also shows no FISH signal for no probe control. Scale bar = 10µm. 
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Discussion 
In this chapter, I showed the subcellular co-localization of the main molecular machinery 
required for protein translation, ribosomes and mRNAs, in peripheral processes of 
astrocytes. This evidence represents a novel first step supporting my main hypothesis about 
the presence of local translation in astrocytes at the tripartite synapse. Furthermore, the 
astrocyte-specific mRNAs the lab identified via the novel PAP TRAP method encode proteins 
with interesting functional roles with implications in neural health and disease. I validated 
the localization of these mRNAs in vivo, confirming both the phenomenon of subcellular 
localization and the biochemical method of localizing particular mRNAs to assist with the 
aforementioned astrocyte functions. Broadly speaking, the advantages of subcellular RNA 
localization to an astrocyte could be twofold: (a) an energy advantage since multiple proteins 
can be synthesized from a single mRNA and energy does not need to be expended trafficking 
protein to/from the synapse, and (b) a kinetic advantage since stimulus response can happen 
on-site rather than following the delay associated with signal transduction to the nucleus 
and protein trafficking. In these respects, mRNA localization can be thought of as a method 
for spatial regulation of gene expression. 
Specifically, glutamate is the predominant excitatory neurotransmitter in the CNS and is 
involved in numerous key brain functions including learning and memory. However, 
excessive synaptic accumulation of glutamate is associated with neuronal death and brain 
damage36. Furthermore, glutamate accumulation and associated excitotoxicity has been 
implicated in multiple neurological diseases including Alzheimer’s disease, Huntington’s 
disease, seizure disorders, and more36,37. Astrocytes play a major role in synaptic clearance 
of glutamate, limiting activation of post-synaptic glutamate receptors via expression of 
astrocyte-specific glutamate transporters GLT-1 and GLAST38,39. These transporters are 
encoded by Slc1a2 and Slc1a3, respectively. Abnormal Slc1a2 mRNAs40 and a selective loss 
of GLT-141 have been identified in the motor cortex of ALS patients, leading to hypotheses 
that RNA processing dysregulation contributes to the pathophysiology of neurodegenerative 
disease. Human Slc1a3 mutations have been associated with episodic ataxia, hemiplegia, and 
seizures as reported in a 2005 case study42, and GLAST-deficient mice show optic nerve 
degeneration similar to that observed in glaucoma43. I also visualized peripherally localized 
Glul mRNA, which encodes glutamine synthetase (GS; a.k.a. glutamate-ammonia ligase, or 
GLUL), a key enzyme also involved in synaptic glutamate metabolism by catalyzing 
glutamate conversion to glutamine. Astrocyte GS levels increase rapidly after ischemia in 
response to ischemic glutamate excitotoxicity44, and GS levels are also significantly 
decreased in the prefrontal cortex of an Alzheimer’s disease mouse model45. My results 
demonstrating localization of Slc1a2, Slc1a3, and Glul mRNA at peripheral processes 
suggests that aberrant translation of these three major astrocyte-specific glutamate 
regulators could greatly contribute to glutamate accumulation and associated 
neurodegeneration. 
In addition to functional roles in glutamate clearance, in the past decade, astrocytes have 
emerged as important regulators of synaptic connectivity46. The Sparc mRNA I demonstrated 
as peripherally localized encodes the secreted protein acidic and rich in cysteine (SPARC). 
This protein allows for astrocytes to dynamically regulate excitatory synaptogenesis by 
antagonizing hevin, a positive regulator of synapse formation47. Based on the 
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aforementioned functional roles, local translation to produce SPARC could be a molecular 
mechanism underlying temporal and spatial regulation of synaptic plasticity in the CNS. 
All in all, my work investigates a molecular mechanism for previously characterized 
astrocyte functions. Under the assumption that form implies function, the co-localization of 
ribosomes and astrocyte-specific mRNAs in astrocyte distal processes suggests that: (a) 
ribosomes may synthesize molecular constituents of the synapse, and (b) translation could 
be regulated by synaptic activity at the localized sites. However, even though the discussed 
functional roles of the astrocyte-specific mRNAs I targeted seem to corroborate these 
proposed mechanisms, the presence of translational machinery does not biologically equate 
to the translation and expression of protein. It is plausible that astrocyte mRNA could be 
trafficked to or from peripheral processes prior to translation. Thus, it is important that I 
independently examine local translation itself given that translation has not yet been 
established as the definitive mechanism of astrocyte peripheral responses. Peripheral 
ribosome and mRNA localization serves as the groundwork for Chapter 2 of this work, 
describing the peripheral translation of protein and the effects of synaptic activity 
modulation on translation levels. 
Chapter 2: Investigating Activity-Dependent Regulation of Astrocyte Local 
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Introduction 
A fundamental aspect of astrocyte function in the CNS is sensing and responding to neuronal 
activity2,17,19,48,49. However, as has been discussed, even though the response itself has been 
defined as calcium influxes or regulation of synaptic coverage (see recent review by 
Kacerovsky & Murai50), the activity-dependent astrocyte response is not well-characterized. 
Astrocytes exhibit numerous functional roles that are mediated by neuronal activity. Takano 
et al. demonstrated in vivo that astrocytes translate neural activity into vasodilation to assist 
the brain in increasing blood flow to active brain regions (“functional hyperemia”)51. 
Neuronal activity blockades with TTX have been shown to reduce astrocyte perisynaptic 
density and localization of GLT-1 clusters, while enhanced neuronal activity increased both 
parameters, suggesting that astrocyte-specific glutamate transport is regulated by neurons 
throughout development52. Furthermore, it has been shown that PAPs dynamically remodel 
morphologically following neuronal activity39. These and the following functional roles 
suggest the need for a local synaptic response mechanism. 
Since not much is known in the field, I set up a screen to investigate the regulation of 
astrocyte translation using well-studied drugs. To measure translation, I utilized puromycin 
(PMY), a Tyr-tRNA analog that terminates translation via ribosome-catalyzed covalent 
incorporation into the C-terminus of the nascent polypeptide chain3,53,54. I then detected 
puromycylated nascent chains via immunofluorescence (IF) of an anti-PMY monoclonal 
antibody and an Alexa-conjugated secondary. This is a particularly efficacious way to detect 
translation; rather than detecting translated protein that may have been trafficked post-
translation to the periphery, I detect actively-translating peripheral proteins. To block PMY 
action and confirm that puromycylation is translation-dependent, I utilized anisomycin, an 
inhibitor of translation that blocks the enzyme allowing amino acids to bond together53. 
I selected the following drug treatments based on their potential regulatory influences on 
astrocytes, as described in previous studies:  
Drug Treatment concentration Function 
KCl 5mM Stimulates neuronal activity 
Forskolin 20μM Adenylate cyclase agonist 
MTEP 50nM mGluR5 selective antagonist 
BDNF 50ng/μL Brain-derived neurotrophic factor 
Table 2: Proposed translational modifiers and their demonstrated effects on synaptic components. 
Potassium chloride (KCl) stimulates neuronal activity by promoting neuronal 
depolarization. While neurons are robustly activated by KCl, astrocytes do not ‘fire’ or 
propagate action potentials along their processes5 and are only slightly depolarized by KCl55. 
Furthermore, astrocyte activation via increases in intracellular Ca2+ is triggered by 
transmission of signaling molecules from neurons or neighboring astrocytes (see Chapter 1). 
Thus, I hypothesized that applying a treatment with KCl would increase astrocyte local 
translation secondary to (and predominately due to) neuronal firing. 
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Forskolin is an activator of adenylate cyclase (AC) in membranes and intact cells. In a rapid 
and reversible manner, forskolin treatment causes a 35-fold elevation of cAMP in rat 
cerebral cortical slices (and has been shown to have similar effects on astrocytes56), 
demonstrating its efficacy as a method to modulate physiological roles of cAMP in vivo57. 
cAMP promotes the normal state of differentiated astrocytes by upregulating genes involved 
in maturation, communication, and homeostatic control58. Furthermore, forskolin induces 
changes in the synthesis of a few proteins and drastically changes astrocyte morphology in 
vitro59, including increases in amyloid precursor protein that accumulates into amyloid-β 
plaques in Alzheimer’s disease60. Since astrocyte cAMP production is endogenously 
regulated, by β-adrenergic stimulation at least in part from neurons in vitro63, I posited that 
I could test neuronal regulation of astrocyte translation by upregulating AC-cAMP astrocyte 
pathways with forskolin. 
Metabotropic glutamate receptor subtype 5 (mGluR5) is an astrocyte-specific glutamate 
GPCR that is selectively blocked by the mGluR5 antagonist 3-[(2-methyl-1,3-thiazol-4-
yl)ethynyl]pyridine (MTEP)64. Down-regulation of mGluR5, associated with the mouse 
model of Fragile X Syndrome (Fmrp-/-), underlies GLT-1 down-regulation in this model65. 
Thus, I utilized MTEP to test if neuronal regulation of translating proteins like GLT-1 is 
mGluR5-dependent. 
Brain-derived neurotrophic factor (BDNF), a growth factor involved in synaptic plasticity, 
stimulates local dendritic protein synthesis7. In a prior investigation by members of the lab, 
proposed PAP-enriched genes were subjected to an upstream analysis pathway that 
identified upstream regulators of those transcripts. The results of this query identified BDNF 
as a significant regulator (Figure 5). Since astrocytes are involved in the BDNF recycling 
process66, I hypothesized that treating with recombinant BDNF (an un-recycled form similar 
to endogenous mouse neuronal BDNF) would increase translation levels due to BDNF’s role 
as a PAP transcript regulator. 
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Figure 5: Ten top upstream regulators of PAP-enriched genes. I analyzed astrocyte-specific transcripts 
enriched on PAP ribosomes (as determined by PAP TRAP + RNA-seq described in Chapter 1). I utilized 
Ingenuity Pathway Analysis65 to identify upstsream regulators of these genes, with the top ten most significant 
results displayed above. 
In this chapter, we utilize a new method to quantify the abundance of nascent peptides 
throughout ex vivo astrocytes in acute mouse brain slices labelled with AAV9-GFP. I also 
confirm that PMY is a viable label of ongoing translation by blocking PMY binding with a 
competitive inhibitor, anisomycin. I then treat acute slices with various drugs and synaptic 
activity inducers/suppressers, demonstrating that I can up and downregulate astrocyte 
translation levels. I use a novel metric of translation by quantifying puromyclation 
immunofluorescence via a Sholl-like analysis around the nucleus of labelled astrocytes that 
allows us to identify differences in measured translation based on distance from the nucleus 
and treatment condition. Overall, I show that astrocyte local translation does indeed appear 
to be modulated in a synaptic activity-dependent manner.  
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Methods 
Animals 
See Chapter 1. 
Acute slice preparation and drug treatment 
Using a vibratome, I prepared acute cortical slices (300µm) from AAV9-CBA-IRES-GFP (see 
Chapter 1) P21 mice in artificial cerebrospinal fluid (aCSF, in mM:  125 NaCl, 25 glucose, 25 
NaHCO3, 2.5 KCl, 1.25 NaH2PO4, equilibrated with 95% oxygen-5% CO2 plus 0.5 CaCl2, 3 
MgCl2; 320 mosmol). 5mM KCl, 20μM forskolin (Sigma #F6886), 50nM MTEP (Sigma 
#M4699), and/or 50ng/mL recombinant human/murine/rat BDNF (PeproTech, #450-02) 
were added to slices with 3μM Puromycin (Tocris #40-895-0) in aCSF and allowed to 
incubate for 10 minutes at 37°C. In Anisomycin conditions only, 1mM Anisomycin (Sigma 
#A9789) in aCSF was added to slices 30 minutes before Puromycin at 37°C. I fixed slices with 
4% paraformaldehyde in PBS for 30 minutes, followed by 30 minutes in 30% sucrose and 
freezing in OCT for cryosectioning. 
Immunofluorescence (IF) 
I cryosectioned 40μm sections into PBS from 300μm acute slices frozen in OCT. I incubated 
sections with Rabbit Anti-GFAP (Dako, 1:1000), Chicken Anti-GFP (Aves, 1:1000), and Mouse 
Anti-Puromycin (Kerafast, 1:1000) at room temperature, followed by detection with 
appropriate Alexa conjugated secondary antibodies (Invitrogen). I counterstained nuclei 
with DAPI. After removing excess buffer, edges of the coverslip were sealed with nail polish 
before imaging. 
Microscopy 
I performed confocal microscopy on an AxioImager Z2 (Zeiss). Representative images are 
from at least triplicate experiments. 
Image quantification 
 
Figure 6: Overview of puromycin quantification methodology used to measure local translation in 
GFP+ astrocytes. A GFP+ astrocyte is imaged, puromycin IF that is co-localized with GFP IF is selected, and 
pixel intensity of both GFP and puromycin IF are measured. 
To determine the distribution of translation occurring in the astrocyte, I drew Sholl-like 
concentric rings around the nucleus with increasing radii of 3μm. I empirically determined 
that a 30µm radius encapsulates most of an astrocyte without overlapping with neighboring 
astrocytes, which is similar to the literature value of mean recorded rodent astrocyte 
AAV9 GFP GFP + Puro binary GFP + Puro intensity
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diameter (56µm)66. I then masked all PMY-IF outside of GFP+ areas and measured the PMY-
IF and GFP+ intensity within each ring (see above, adapted from literature35). 
Statistical analysis 
I used R 3.3.2 software for all statistical analyses of quantification data. Most data were 
analyzed (after log transformation) by repeated measures ANOVA for main effects of 
condition and distance followed by post hoc Wilcoxon rank sum tests for pairwise 
comparisons. I adjusted p-values using Bonferroni multiple test corrections. 
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Results 
Astrocytes synthesize proteins at PAPs ex vivo 
As outlined in Chapter 1, I demonstrated the presence of both ribosomes and mRNA in PAPs, 
so my logical next step was to test whether this machinery produces protein. I did so using 
PMY to label actively translating nascent polypeptides in acute brain slices (Figure 7A). Using 
a PMY antibody for IF in astrocytes labelled sparsely with AAV9-GFP, I was able to detect 
translation within PAPs. I also demonstrated blockage of translation with anisomycin, 
indicating that PMY-IF labelling requires active translation (Figure 7B). I quantified the total 
astrocyte translation from cell body to distal process by measuring PMY-IF intensity at all 
points co-localized with GFP (Figure 7C). This data revealed that anisomycin significantly 
blocks PMY labelling. 
Figure 7: Actively-translating proteins are present in PAPs. (A) Acute slices (300µM) from P21 mice with 
sparse astrocyte labeling (generated as in Figure 3A) are treated for 10 minutes with puromycin with or 
without 30 minutes of anisomycin pretreatment and are then fixed, sectioned, and processed for IF against 
puromycin(red), and GFP(green). (B) IF of puromycylation (PMY) of nascent proteins in a GFP-labelled 
astrocyte shows that translation occurs in peripheral processes, and is blocked by pretreatment with 
anisomycin, scale bar = 10µm. (C) Quantification of percent of GFP pixels co-localized with PMY pixels at 
increasing distances from nucleus indicates that translation occurs robustly across the astrocyte periphery. No 
puromycin control had no PMY pixels (data not shown). Repeated measures ANOVA revealed main effects of 
condition F(2, 138) = 9.694, p = 0.0001 and distance F(8, 1104) = 19.023, p < 2E-16 with a significant interaction 
between condition and distance F(16, 1104) = 2.019, p = 0.01. Data represented as mean ± SEM. Asterisks 
represent Wilcoxon rank sums test with Bonferroni correction, post hoc. ****p < 0.001. N = 40 and 37 cells for 
PMY and AP conditions, respectively.  
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Synaptic activity regulates astrocyte local translation levels ex vivo 
After detecting PMY and quantifying PMY-IF to measure translation levels across astrocyte 
processes, I utilized the newly validated methodology to test astrocyte response to synaptic 
modulation. I treated ex vivo astrocytes (labelled with AAV9-GFP) in acute brain slices with 
the drugs listed in Table 2, and simultaneously with PMY for 10 minutes as described in the 
methods. Once again, I used a PMY antibody for IF (Figure 8A) and found that treating with 
BDNF, forskolin, and KCl significantly increased the PMY-IF signal within astrocytes, 
whereas MTEP and anisomycin decreased the PMY-IF signal (Figure 8B). These data indicate 
that BDNF, forskolin, and KCl significantly upregulate translation in astrocytes, whereas 
MTEP and anisomycin significantly downregulate translation. 
I also examined the dependence of KCl-stimulated increases in translation on mGluR5. This 
experiment was designed to test whether I could stimulate an acute slice with KCl, but block 
or abrogate local translation increases by inhibiting mGluR5 with MTEP (Figure 8C). I pre-
treated slices with MTEP for 10 minutes prior to treating with KCl and PMY for 10 minutes 
as usual. Based on a comparison between PMY-IF signal from KCl treated and KCl + MTEP 
treated slices, MTEP significantly (p < 0.001) blocks KCl-induced local translation increases 
outside of a 6µm radius around the astrocyte cell body (see Table 3). 
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Figure 8: Peripheral astrocyte translation levels change in response to synaptic modulators in vivo. 
Slice/IF preparation as described in Figure 4. Drug treatments are applied with puromycin for 10 minutes. (A) 
IF of puromycylation (PMY) of nascent proteins in a GFP-labelled astrocyte shows that translation is up-
regulated by KCl, BDNF, and SR 141716A and down-regulated by MTEP. (B) Quantification of percent of GFP 
pixels co-localized with PMY pixels at increasing distances from nucleus indicates that translation is regulated 
as observed in Figure 5A. Repeated measures ANOVA across all data revealed main effect of condition F(8, 258) 
= 40.02, p < 2.2E-16, but not distance F(9, 2322) = 1.055, p = 0.393, with a significant interaction between 
condition and distance F(8,258) = 5.458, p < 2.2E-16. Data presented are mean ± SEM. For post hoc statistics, 
see Table 3 (below). N(A+PMY) = 37 cells, N(BDNF) = 13, N(Forskolin) = 45, N(KCl) = 44, N(MTEP) = 39, N(PMY 
only) = 40. (C) MTEP abrogates KCl-stimulated increases in local translation throughout the periphery. Acute 
slices were pre-treated for 10 minutes with MTEP followed by 10 minutes with KCl and PMY. Data presented 
are mean ± SEM. For post hoc statistics, see Table 3 (below). N(KCl) = 44 cells, N(KCl + MTEP) = 10, N(MTEP) = 
39, N(PMY only) = 40. 
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Distance (µm) Comparison BonfP value Significance level 
30 Kcl > P 1.21E-05 **** 
27 Kcl > P 1.68E-05 **** 
24 Kcl > P 3.10E-07 **** 
21 Kcl > P 1.56E-08 **** 
18 Kcl > P 2.73E-06 **** 
15 Kcl > P 4.12E-06 **** 
12 Kcl > P 4.12E-06 **** 
9 Kcl > P 4.12E-06 **** 
6 Kcl > P 5.16E-10 **** 
3 Kcl > P 2.09E-07 **** 
30 AP < P 5.93E-05 **** 
27 AP < P 6.00E-10 **** 
24 AP < P 8.08E-10 **** 
21 AP < P 1.56E-08 **** 
18 AP < P 6.55E-08 **** 
15 AP < P 8.44E-09 **** 
12 AP < P 5.43E-10 **** 
9 AP < P 3.67E-08 **** 
6 AP < P 5.12E-08 **** 
3 AP < P 1.10E-07 **** 
18 MTEP < P 0.03901 * 
15 MTEP < P 0.00414 *** 
12 MTEP < P 0.03366 * 
30 BDNF > P 1.14E-05 **** 
27 BDNF > P 1.12E-06 **** 
24 BDNF > P 9.97E-08 **** 
21 BDNF > P 3.59E-07 **** 
18 BDNF > P 5.75E-07 **** 
15 BDNF > P 1.70E-07 **** 
12 BDNF > P 9.97E-08 **** 
9 BDNF > P 9.02E-07 **** 
6 BDNF > P 5.57E-09 **** 
3 BDNF > P 8.07E-09 **** 
30 KCl > KclMTEP 1.98E-09 **** 
27 KCl > KclMTEP 4.18E-09 **** 
24 KCl > KclMTEP 3.37E-10 **** 
21 KCl > KclMTEP 2.06E-11 **** 
18 KCl > KclMTEP 3.11E-09 **** 
15 KCl > KclMTEP 3.61E-09 **** 
12 KCl > KclMTEP 3.11E-09 **** 
9 KCl > KclMTEP 8.53E-09 **** 
6 KCl > KclMTEP 2.65E-05 **** 
3 KCl > KclMTEP 0.00370 *** 
Table 3: Significant post hoc Wilcoxon rank sum test statistics for Figures 8B and 8C. ****p < 0.001, ***p 
< 0.005, **p < 0.01, *p < 0.05. Comparisons/distances not shown did not meet statistical significance criteria.  
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Discussion 
Overall, my data shows that, as hypothesized, astrocytes do have shifts in local translation 
levels in response to various synaptic modulators. In particular, it appears astrocytic 
activation via KCl-induced neuronal depolarization is dampened by mGluR5 inhibition, 
suggesting the possibility of an mGluR5-dependent mechanism of astrocyte activation. This 
is consistent with literature hypotheses about activity-dependent mGluR5 regulation of 
glutamate transport via GLT-152. 
Figure 9: Cartoon of proposed mGluR5-dependent mechanism of astrocyte activation via KCl. (A) KCl 
induces action potential firing in the presynaptic neuron, leading to glutamate release. Glutamate binds 
astrocytic mGluR5, resulting in increased local translation at perisynaptic processes. (B) MTEP treatment 
inhibits glutamate binding to mGluR5, blocking local translation increases in astrocyte perisynaptic processes. 
While my model (Figure 9) shows that KCl treatment leads to astrocyte stimulation via 
neuronal depolarization and subsequent neurotransmitter release, it is important to also 
acknowledge that KCl does stimulate and mildly depolarize astrocytes, leading to Ca2+ influx 
and gliotransmitter release55. Furthermore, neuron-astrocyte direct communication is likely 
not the only mechanism at work given the ex vivo model; very recent findings demonstrate 
that neuroinflammatory microglia induce astrocyte reactivity and cause neurotoxic 
phenotypes including the induction of neuron and oligodendrocyte death67. These findings 
emphasize the importance of the lab’s future experiments to block neuronal activity with 
tetradotoxin prior to KCl treatment ex vivo, and to test cell-autonomous astrocyte 
functioning in response to treatment with KCl and drugs via an in vitro primary cortical 
astrocyte culture model. 
mGluR5 down-regulation occurs in a Fragile X Syndrome (FXS) mouse and underlies 
astrocytic GLT-1 dysregulation, contributing to enhanced neuronal excitability that is 
hallmark of the FXS mouse model65. Furthermore, mGluR5 dysregulation is implicated in 
long-term depression (LTD) effects on synaptic plasticity/working memory impairment in 
FXS68. Thus, the fact that MTEP abrogates a KCl-induced, activity-dependent translational 
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increase suggests that perhaps the dysregulation of mGluR5 relates to neurotoxicity induced 
by GLT-1 dysregulation in FXS and other models of asotrocyte-related neurotoxicity. Further 
investigation of this mechanism could elucidate the biochemical mechanism of astrocyte-
neuron communication disruption in FXS and other diseases of synaptic dysfunction. 
Prior to these activity-dependence studies, I proposed a protein-specific method of assessing 
local translation through use of the newly developed proximity ligation assay (PLA)69. My 
goal was to have single protein resolution for greater specificity in measuring the proteomic 
responses characterized in this work. In this method, acute brain slices are incubated briefly 
with puromycin (PMY) to stop peptide elongation. Anti-PMY and Anti-N-terminal protein of 
interest antibodies are used and then detected with specific PLA secondaries. These 
secondaries interact by their conjugated, linked oligonucleotides and allow detection by a 
complementary fluorescent probe (protocol summarized from Dieck et al. 2015)70. While 
this protocol has not yet been successful in our lab, the development of a sequence-specific 
translational measurement method of this nature would be an optimal way to delve deeper 
into local translation mechanisms. For example, I could test the hypothesis generated from 
my results that neuronal activity-dependent activation of astrocytes occurs in an mGluR5-
dependent manner, as I hypothesize would be reflected by GLT-1 downregulation when 
mGluR5 is blocked with MTEP. Furthermore, with the ability to test any individual protein, I 
could test for local translation of any of the PAP-enriched transcripts the lab identified by 
PAP TRAP. These studies would establish local translation as an astrocyte response 
mechanism with specific functional implications. 
While my initial data is promising, the lab’s future plans include attempting to recapitulate 
my puromycin immunofluorescence results in vitro with cultured primary cortical 
astrocytes to test whether or not astrocyte local translation is a cell-autonomous function. 
Furthermore, I am considering experiments to block neuronal action potentials via 
tetradotoxin (TTX), which has been shown to reduce GLT-1 perisynaptic density in vivo52. 
Combining this blockade with KCl, BDNF, or forskolin treatment would be a good way to 
examine whether astrocyte local translation regulation is indeed due to neuronal synaptic 
activity rather than cell-autonomous astrocyte functions. Another proposed experiment is 
utilizing PAP TRAP + RNA-seq to characterize the PAP transcriptome after drug or ion-
induced synaptic activity. This would be a high-throughput method and would utilize 
functional genomics to identify the roles of PAP-enriched mRNAs that are increasingly 
localized and loaded onto ribosomes under, for example, in vivo KCl-induced neuronal 
depolarization conditions. 
All in all, my thesis summarizes data backing up a few hypotheses about astrocyte functional 
mechanisms. Firstly, as explored in Chapter 1, astrocytes regulate local responses by 
subcellular RNA localization; mRNAs specific to perisynaptic astrocyte function are co-
localized with astrocyte ribosomes in peripheral astrocyte processes. Furthermore, as 
assessed in Chapter 2, astrocyte translation is regulated locally and modulates in response 
to changes at the synapse. Local regulation of translation and subcellular localization of 
mRNAs are two mechanisms by which astrocytes sustain their role maintaining synaptic 
health and facilitating healthy neurotransmission, and continued exploration of these 
mechanisms can provide insight into how astrocytes impact diseases of synaptic 
dysfunction.
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